BIOSERVO TECHNOLOGIES AB Financials Bioservo Technologies AB
Equities
10B
SE0009779085
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.05 EUR | -.--% |
|
-.--% | -.--% |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 136.4 | 89.47 | 202.1 | 268.8 | 180.4 | 47.84 |
| Enterprise Value (EV) 1 | 89.53 | 63.91 | 145.1 | 216.2 | 128.9 | 22.83 |
| P/E ratio | -6.34 x | -3.21 x | -6 x | -10.3 x | -4.55 x | -0.66 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 11.5 x | 5.71 x | 8.46 x | 19 x | 17.1 x | 3.48 x |
| EV / Revenue | 7.57 x | 4.08 x | 6.07 x | 15.3 x | 12.2 x | 1.66 x |
| EV / EBITDA | -4.89 x | -2.97 x | -6.32 x | -7.06 x | -3.81 x | -0.46 x |
| EV / FCF | -5.9 x | -4.86 x | -7.96 x | -19.4 x | -5.65 x | -0.68 x |
| FCF Yield | -17% | -20.6% | -12.6% | -5.15% | -17.7% | -147% |
| Price to Book | 2.01 x | 2.23 x | 2.68 x | 4.77 x | 2.87 x | 1.28 x |
| Nbr of stocks (in thousands) | 8,936 | 8,936 | 14,298 | 14,298 | 18,958 | 28,437 |
| Reference price 2 | 15.26 | 10.01 | 14.13 | 18.80 | 9.516 | 1.682 |
| Announcement Date | 4/6/18 | 4/11/19 | 4/2/20 | 3/26/21 | 3/31/22 | 3/28/23 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 11.83 | 15.67 | 23.89 | 14.15 | 10.53 | 13.76 |
| EBITDA 1 | -18.29 | -21.52 | -22.98 | -30.61 | -33.83 | -49.61 |
| EBIT 1 | -18.38 | -22.03 | -23.24 | -31 | -34.31 | -50.42 |
| Operating Margin | -155.32% | -140.57% | -97.28% | -219.11% | -325.87% | -366.37% |
| Earnings before Tax (EBT) 1 | -19.31 | -22.19 | -23.25 | -26.32 | -34.67 | -50.5 |
| Net income 1 | -19.31 | -27.89 | -23.25 | -26.32 | -34.67 | -50.5 |
| Net margin | -163.16% | -178% | -97.3% | -186.08% | -329.3% | -366.92% |
| EPS 2 | -2.407 | -3.121 | -2.354 | -1.823 | -2.090 | -2.560 |
| Free Cash Flow 1 | -15.19 | -13.16 | -18.22 | -11.14 | -22.82 | -33.47 |
| FCF margin | -128.33% | -83.96% | -76.27% | -78.78% | -216.78% | -243.19% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/6/18 | 4/11/19 | 4/2/20 | 3/26/21 | 3/31/22 | 3/28/23 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 2.94 | 3.561 | 1.884 | 1.259 | 4.625 | 1.201 | 4.157 |
| EBITDA 1 | - | -10.97 | -9.77 | -15.48 | -8.934 | -11.4 | -9.314 |
| EBIT 1 | - | -11.78 | -10.71 | -15.96 | -9.391 | -11.9 | -9.76 |
| Operating Margin | - | -330.95% | -568.47% | -1,267.43% | -203.05% | -990.67% | -234.78% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - |
| Net income | -12.12 | - | - | - | - | - | - |
| Net margin | -412.28% | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 5/3/22 | 8/30/22 | 11/15/22 | 2/22/23 | 4/25/23 | 8/18/23 | 11/7/23 |
1SEK in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 46.9 | 25.6 | 56.9 | 52.6 | 51.5 | 25 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -15.2 | -13.2 | -18.2 | -11.1 | -22.8 | -33.5 |
| ROE (net income / shareholders' equity) | -39.4% | -51.7% | -40.3% | -38.3% | -55.4% | -101% |
| ROA (Net income/ Total Assets) | -20.8% | -22.5% | -22.1% | -25.5% | -29.8% | -50% |
| Assets 1 | 92.76 | 124.2 | 105.2 | 103.2 | 116.5 | 101 |
| Book Value Per Share 2 | 7.580 | 4.490 | 5.260 | 3.940 | 3.310 | 1.320 |
| Cash Flow per Share 2 | 5.240 | 2.860 | 3.980 | 3.330 | 2.720 | 0.8800 |
| Capex 1 | 0.22 | 0.5 | 0.03 | - | - | 0.14 |
| Capex / Sales | 1.83% | 3.22% | 0.11% | - | - | 1% |
| Announcement Date | 4/6/18 | 4/11/19 | 4/2/20 | 3/26/21 | 3/31/22 | 3/28/23 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 4.6M | |
| +8.07% | 219B | |
| +7.87% | 184B | |
| +12.75% | 138B | |
| -1.37% | 62.54B | |
| +4.88% | 52.22B | |
| +11.59% | 51.73B | |
| +2.71% | 41.4B | |
| +4.90% | 37.17B | |
| +23.75% | 31.76B |
- Stock Market
- Equities
- 10B Stock
- Financials Bioservo Technologies AB